STAA logo

STAAR Surgical (STAA) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

24 February 1992

Indexes:

Not included

Description:

STAAR Surgical Company is a leading manufacturer of lenses used worldwide in corrective surgery. The corporation has been in operation since 1982 and is based in Springfield, Massachusetts. STAAR Surgical Company designs, develops, manufactures, and markets implantable lenses for the eyes and systems used to deliver lenses to the eye. STAAR conducts business worldwide, with approximately 95% of its sales volume coming from outside the US. The company sells its products in over 75 countries, through direct sales in Japan, Spain, the US, Germany, Canada, the UK, and Singapore, and through distributors and representatives in China, Korea, and India.

Key Details

Price

$28.60

Annual Revenue

$322.42 M(+13.37% YoY)

Annual EPS

$0.43(-46.25% YoY)

PE Ratio

65.00(-20.51% YoY)

Beta

1.59

Events Calendar

Earnings

Next earnings date:

Feb 26, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Feb 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 18, 1992

Analyst ratings

Recent major analysts updates

01 Nov '24 Canaccord Genuity
Hold
31 Oct '24 Needham
Hold
19 Sept '24 Needham
Hold
26 Aug '24 Stifel
Buy
08 Aug '24 Needham
Hold
08 Aug '24 Canaccord Genuity
Hold
15 July '24 Needham
Hold
15 July '24 Morgan Stanley
Underweight
15 July '24 BTIG
Buy
11 June '24 BTIG
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts
A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts
A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts
STAA
zacks.com04 November 2024

Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript
STAA
seekingalpha.com30 October 2024

STAAR Surgical Company (NASDAQ:STAA ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Brian Moore - VP, IR Tom Frinzi - Chair, President and CEO Patrick Williams - CFO Conference Call Participants Tom Stephan - Stifel Ryan Zimmerman - BTIG Patrick Wood - Morgan Stanley Operator Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, October 30th, 2024.

Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention
STAA
zacks.com12 August 2024

Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

STAAR Surgical Company (STAA) Q2 2024 Earnings Call Transcript
STAAR Surgical Company (STAA) Q2 2024 Earnings Call Transcript
STAAR Surgical Company (STAA) Q2 2024 Earnings Call Transcript
STAA
seekingalpha.com09 August 2024

STAAR Surgical Company (NASDAQ:STAA ) Q2 2024 Earnings Conference Call August 7, 2024 4:15 PM ET Company Participants Brian Moore – Vice President of Investor Relations Tom Frinzi - Chair of the Board, President & Chief Executive Officer Patrick Williams - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Tom Stephan - Stifel Margaret Kaczor Andrew - William Blair David Saxon - Needham Anthony Petrone - Mizuho George Sellers - Stephens John Young - Canaccord Operator Greetings and welcome to the STAAR Surgical Second Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, August 7, 2024.

Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates
Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates
Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates
STAA
zacks.com07 August 2024

Staar Surgical (STAA) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.40 per share a year ago.

Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock
STAA
Zacks Investment Research13 May 2024

Examine how Staar Surgical's (STAA) international revenue results impact financial analysts' forecasts on Wall Street and the stock's future outlook.

Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
STAA
Zacks Investment Research05 April 2024

Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

What's going on with STAAR Surgical shares?
What's going on with STAAR Surgical shares?
What's going on with STAAR Surgical shares?
STAA
Invezz05 April 2024

STAAR Surgical (NASDAQ: STAA) received an upgrade from William Blair on Friday. The stock has been moved from Market Perform to Outperform status.

Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
STAA
Zacks Investment Research27 February 2024

The headline numbers for Staar Surgical (STAA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript
STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript
STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript
STAA
Seeking Alpha26 February 2024

STAAR Surgical Company (STAA) Q4 2023 Earnings Call Transcript

  • 1(current)
  • 2
  • 1(current)
  • 2

FAQ

  • What is the primary business of STAAR Surgical?
  • What is the ticker symbol for STAAR Surgical?
  • Does STAAR Surgical pay dividends?
  • What sector is STAAR Surgical in?
  • What industry is STAAR Surgical in?
  • What country is STAAR Surgical based in?
  • When did STAAR Surgical go public?
  • Is STAAR Surgical in the S&P 500?
  • Is STAAR Surgical in the NASDAQ 100?
  • Is STAAR Surgical in the Dow Jones?
  • When was STAAR Surgical's last earnings report?
  • When does STAAR Surgical report earnings?
  • Should I buy STAAR Surgical stock now?

What is the primary business of STAAR Surgical?

STAAR Surgical Company is a leading manufacturer of lenses used worldwide in corrective surgery. The corporation has been in operation since 1982 and is based in Springfield, Massachusetts. STAAR Surgical Company designs, develops, manufactures, and markets implantable lenses for the eyes and systems used to deliver lenses to the eye. STAAR conducts business worldwide, with approximately 95% of its sales volume coming from outside the US. The company sells its products in over 75 countries, through direct sales in Japan, Spain, the US, Germany, Canada, the UK, and Singapore, and through distributors and representatives in China, Korea, and India.

What is the ticker symbol for STAAR Surgical?

The ticker symbol for STAAR Surgical is NASDAQ:STAA

Does STAAR Surgical pay dividends?

No, STAAR Surgical does not pay dividends

What sector is STAAR Surgical in?

STAAR Surgical is in the Healthcare sector

What industry is STAAR Surgical in?

STAAR Surgical is in the Medical Instruments & Supplies industry

What country is STAAR Surgical based in?

STAAR Surgical is headquartered in United States

When did STAAR Surgical go public?

STAAR Surgical's initial public offering (IPO) was on 24 February 1992

Is STAAR Surgical in the S&P 500?

No, STAAR Surgical is not included in the S&P 500 index

Is STAAR Surgical in the NASDAQ 100?

No, STAAR Surgical is not included in the NASDAQ 100 index

Is STAAR Surgical in the Dow Jones?

No, STAAR Surgical is not included in the Dow Jones index

When was STAAR Surgical's last earnings report?

STAAR Surgical's most recent earnings report was on 30 October 2024

When does STAAR Surgical report earnings?

The next expected earnings date for STAAR Surgical is 26 February 2025

Should I buy STAAR Surgical stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions